8 A prospective cohort study involving seven psoriasis patients with type 2 diabetes treated with liraglutide for 12 weeks observed a mean PASI decrease from 15.7 to 2.2 and a DLQI improvement from 21.8 to 4.1.9 Additionally, reductions in HbA1c, BMI, and waist circumference were observed.9 One randomized, placebo-controlled trial involving 20 obese, glucose-tolerant patients with plaque psoriasis, however, found no significant improvement in PASI after 8 weeks of liraglutide
Many users discover that with adjustments in dosage, dietary changes, or even temporary medication pauses, the journey becomes smoother
FMT, faecal microbiota transplantation
The effects of surgery for endometriosis on pregnancy outcomes following in vitro fertilization and embryo transfer: a systematic review and meta-analysis
Efficacy and safety of oral Orforglipron in patients with type 2 diabetes: a multicentre, randomised, dose-response, phase 2 study
Practitioners can consider the following strategies: Antioxidant Supplementation: Supplementing with glutathione or its precursors (such as cysteine) may help in restoring the balance of reduced and oxidized glutathione
/assets/images/provider/photos/2775905.jpeg)
